levetiracetam

Ukraine

Drugs containing this active substance

  • DESAYZ®

    The drug is used for the treatment of epilepsy. It can be used as monotherapy for partial seizures in adults and adolescents aged 16 and older, as well as adjunctive therapy for children from 6 years of age and adults for various forms of epileptic seizures (partial, myoclonic, or primary generalized).

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 250 mg

    ATC: N03AX14

    Manufacturer: Rontis Hellas Medical and Pharmaceutical Products S.A. (manufacturing of granules and finished product, primary and secondary packaging, batch control, batch release)

  • The drug is used for the treatment of epilepsy. It can be used as monotherapy for partial seizures in adults and adolescents aged 16 years and older, as well as adjunctive therapy for children from 6 years of age and adults for various forms of epileptic seizures.

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 1000 mg

    ATC: N03AX14

    Manufacturer: Rontis Hellas Medical and Pharmaceutical Products S.A. (manufacturing of granules and finished product, primary and secondary packaging, batch control, batch release)

  • The drug is used for the treatment of epilepsy. It may be prescribed as monotherapy for partial seizures in adults and adolescents aged 16 years and older, as well as adjunctive therapy for adults and children (from 6 years old) for various forms of epileptic seizures.

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 500 mg

    ATC: N03AX14

    Manufacturer: Rontis Hellas Medical and Pharmaceutical Products S.A. (manufacturing of granules and finished product, primary and secondary packaging, batch control, batch release)

  • The drug is used for the treatment of epilepsy. It is prescribed as monotherapy for partial seizures in adults and adolescents aged 16 years and older, as well as adjunctive therapy for children from 6 years of age, adolescents, and adults for various forms of epileptic seizures (partial, myoclonic, or primary generalized).

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 250 mg

    ATC: N03AX14

    Manufacturer: USB Pharma

  • The drug is used for the treatment of epilepsy. It is prescribed as monotherapy for partial seizures in adults and adolescents aged 16 years and older, as well as adjunctive therapy for children from 6 years of age, adolescents, and adults for various forms of epileptic seizures (partial, myoclonic, or primary generalized).

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 500 mg

    ATC: N03AX14

    Manufacturer: USB Pharma

  • The drug is used to treat epilepsy. It is prescribed as monotherapy for partial seizures in adults and adolescents aged 16 and older, as well as adjunctive therapy for children from 6 years of age, adolescents, and adults for various forms of epileptic seizures (partial, myoclonic, or primary generalized).

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 1000 mg

    ATC: N03AX14

    Manufacturer: USB Pharma

  • The drug is used for the treatment of epilepsy. It is prescribed as monotherapy for partial seizures in adults and adolescents aged 16 years and older. It is also used as adjunctive therapy for the treatment of partial seizures in adults and children from 1 month of age, myoclonic seizures in adults and adolescents aged 12 years and older, as well as primary generalized tonic-clonic seizures in adults and adolescents aged 12 years and older.

    Form: solution, oral

    Active substance Dosage
    levetiracetam 100 mg/ml

    ATC: N03AX14

    Manufacturer: NextPharma SAS

  • The drug is used for the treatment of epilepsy. It is prescribed as monotherapy for partial seizures in adults and adolescents aged 16 years and older, as well as adjunctive therapy for children from 6 years of age, adolescents, and adults for various forms of epileptic seizures (partial, myoclonic, or primary generalized).

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 250 mg

    ATC: N03AX14

    Manufacturer: Farmaten International SA (alternative primary packaging, secondary packaging)

  • The drug is used for the treatment of epilepsy. It is prescribed as monotherapy for partial seizures in adults and adolescents aged 16 and older, as well as adjunctive therapy for children from 6 years of age, adolescents, and adults for various forms of seizures (partial, myoclonic, or primary generalized seizures).

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 500 mg

    ATC: N03AX14

    Manufacturer: Farmaten International SA (alternative primary packaging, secondary packaging)

  • The drug is used for the treatment of epilepsy. It is prescribed both as monotherapy (as a primary treatment) for partial seizures in adults and adolescents aged 16 and older, and as adjunctive therapy for children from 6 years of age and adults with various forms of seizures (partial, myoclonic, or primary generalized).

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 250 mg

    ATC: N03AX14

    Manufacturer: Jubilant Generics Limited

  • The drug is used for the treatment of epilepsy. It is prescribed both as monotherapy (as a primary treatment) for partial seizures in adults and adolescents aged 16 years and older, and as adjunctive therapy for children from 6 years of age and adults with various forms of seizures (partial, myoclonic, or primary generalized seizures).

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 500 mg

    ATC: N03AX14

    Manufacturer: Jubilant Generics Limited

  • The drug is used for the treatment of epilepsy. It is prescribed as monotherapy for the initial treatment of partial seizures in adults and adolescents aged 16 years and older. It may also be used as adjunctive therapy for the treatment of partial seizures, myoclonic seizures, or generalized seizures in adults and children (from 6 years of age, depending on the seizure type).

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 1000 mg

    ATC: N03AX14

    Manufacturer: Jubilant Generics Limited

  • The drug is used for the treatment of epilepsy. In adults and adolescents aged 16 and older, it may be used as a primary treatment for the diagnosis of partial seizures. It is also used as adjunctive therapy for partial seizures (children from 6 years old), myoclonic seizures (from 12 years old), and primary generalized seizures (from 12 years old).

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 750 mg

    ATC: N03AX14

    Manufacturer: Jubilant Generics Limited

  • The drug is used for the treatment of epilepsy. It can be used as monotherapy for partial seizures in adults and adolescents aged 16 years and older, or as adjunctive therapy for children from 4 years of age, as well as for myoclonic seizures and primary generalized tonic-clonic seizures.

    Form: concentrate for infusion solution

    Active substance Dosage
    levetiracetam 100 mg/ml

    ATC: N03AX14

    Manufacturer: Aspiron Pharma Limited

  • The drug is used for the treatment of epilepsy. It is prescribed as monotherapy for partial seizures in adults and adolescents aged 16 and older, as well as adjunctive therapy for children from 6 years of age, adolescents, and adults with various forms of seizures (partial, myoclonic, or generalized).

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 250 mg

    ATC: N03AX14

    Manufacturer: Hetero Labs Limited

  • The drug is used for the treatment of epilepsy. In adults and adolescents aged 16 and older, it may be used as monotherapy for partial seizures. It is also prescribed as adjunctive therapy for the treatment of partial seizures, myoclonic seizures, and generalized seizures in various age groups.

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 500 mg

    ATC: N03AX14

    Manufacturer: Hetero Labs Limited

  • The drug is used for the treatment of epilepsy. It can be used as monotherapy for partial seizures in adults and adolescents aged 16 and older, as well as adjunctive therapy for children from 6 years of age, adolescents, and adults with various forms of seizures (partial, myoclonic, or generalized).

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 1000 mg

    ATC: N03AX14

    Manufacturer: Hetero Labs Limited

  • The drug is used for the treatment of epilepsy. It is indicated as monotherapy for partial seizures in adults and adolescents aged 16 years and older, as well as adjunctive therapy for various forms of epileptic seizures in adults and children aged 6 years and older.

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 250 mg

    ATC: N03AX14

    Manufacturer: WORLD MEDICINE ILAC SAN. VE TIC. A.S.

  • The drug is used for the treatment of epilepsy. It is prescribed as monotherapy for partial seizures in adults and adolescents aged 16 years and older, as well as adjunctive therapy for various forms of epileptic seizures in adults and children from 6 years of age.

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 500 mg

    ATC: N03AX14

    Manufacturer: WORLD MEDICINE ILAC SAN. VE TIC. A.S.

  • The drug is used for the treatment of epilepsy. It is prescribed as primary treatment for the first manifestations of partial seizures in adults and adolescents aged 16 years and older. It can also be used as adjunctive therapy for children from 6 years of age and adults for various forms of seizures (partial, myoclonic, or generalized seizures).

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 1000 mg

    ATC: N03AX14

    Manufacturer: WORLD MEDICINE ILAC SAN. VE TIC. A.S.

  • The drug is used for the treatment of epilepsy. It is prescribed as monotherapy for partial seizures in adults and children aged 16 years and older, as well as adjunctive therapy for various forms of epileptic seizures in adults and children aged 6 years and older (depending on the seizure type).

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 250 mg

    ATC: N03AX14

    Manufacturer: San Pharmaceutical Industries Ltd

  • The drug is used for the treatment of epilepsy. It is prescribed as monotherapy for partial seizures in adults and children aged 16 years and older. It may also be used as adjunctive therapy for various forms of epileptic seizures in adults and children (from 6 or 12 years of age, depending on the seizure type).

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 500 mg

    ATC: N03AX14

    Manufacturer: San Pharmaceutical Industries Ltd

  • The drug is used for the treatment of epilepsy. It is prescribed as a primary treatment for partial seizures in adults and children aged 16 and older. It may also be used as adjunctive therapy for various forms of epileptic seizures in adults and children (from 6 or 12 years of age, depending on the seizure type).

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 1000 mg

    ATC: N03AX14

    Manufacturer: San Pharmaceutical Industries Ltd

  • The drug is used for the treatment of epilepsy. It is prescribed as monotherapy for partial seizures in adults and adolescents aged 16 years and older, as well as adjunctive therapy for children from 6 years of age, for myoclonic seizures and primary generalized seizures.

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 250 mg

    ATC: N03AX14

    Manufacturer: Farmas Start LLC

  • The drug is used for the treatment of epilepsy. It is prescribed as monotherapy for partial seizures in adults and adolescents aged 16 years and older, as well as adjunctive therapy for children aged 6 years and older, for myoclonic seizures and primary generalized seizures.

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 500 mg

    ATC: N03AX14

    Manufacturer: Farmas Start LLC

  • The drug is used for the treatment of epilepsy. It is prescribed both as monotherapy for partial seizures in adults and adolescents aged 16 years and older, and as adjunctive therapy for children (from 1 month of age) and adults for various forms of epileptic seizures, including myoclonic seizures and generalized seizures.

    Form: solution, oral

    Active substance Dosage
    levetiracetam 100 mg/ml

    ATC: N03AX14

    Manufacturer: Medinfar Manufacturing, S.A. (Manufacturing, packaging)

  • The drug is used for the treatment of epilepsy. It is prescribed as monotherapy for partial seizures in adults and adolescents aged 16 years and older, as well as adjunctive therapy for children from 6 years of age, adolescents, and adults for various forms of epileptic seizures (partial, myoclonic, or primary generalized).

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 250 mg

    ATC: N03AX14

    Manufacturer: Farmas Start LLC

  • The drug is used for the treatment of epilepsy. It is prescribed as monotherapy for partial seizures in adults and adolescents aged 16 years and older, as well as adjunctive therapy for children from 6 years of age and adults for various forms of epileptic seizures (partial, myoclonic, or primary generalized).

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 500 mg

    ATC: N03AX14

    Manufacturer: Farmas Start LLC

  • The drug is used for the treatment of epilepsy. It is prescribed as monotherapy for partial seizures in adults and children aged 16 years and older, as well as adjunctive therapy for the treatment of various types of seizures (partial, myoclonic, and primary generalized) in adults and children of certain ages.

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 750 mg

    ATC: N03AX14

    Manufacturer: San Pharmaceutical Industries Ltd

  • The drug is used for the treatment of epilepsy. It can be used as monotherapy for partial seizures in adults and adolescents aged 16 years and older, as well as adjunctive therapy for children from 6 years of age and adults with various forms of epileptic seizures.

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 500 mg

    ATC: N03AX14

    Manufacturer: Kusum Healthcare Pvt Ltd (manufacturing, primary packaging, secondary packaging, quality control, batch release or manufacturing bulk products)

  • The drug is used for the treatment of epilepsy. It is prescribed as primary treatment for partial seizures in adults and adolescents aged 16 years and older, as well as adjunctive therapy for children aged 6 years and older, for myoclonic seizures and primary generalized tonic-clonic seizures.

    Form: tablets, film-coated

    Active substance Dosage
    levetiracetam 250 mg

    ATC: N03AX14

    Manufacturer: Kusum Healthcare Pvt Ltd (manufacturing, primary packaging, secondary packaging, quality control, batch release or manufacturing bulk products)

  • The drug is used for the treatment of epilepsy. It is prescribed as primary treatment for partial seizures in adults and adolescents aged 16 years and older, as well as adjunctive therapy for children (from 1 month of age), adults, and adolescents with various forms of epileptic seizures (partial, myoclonic, or primary generalized).

    Form: solution, oral

    Active substance Dosage
    levetiracetam 100 mg/ml

    ATC: N03AX14

    Manufacturer: KUSUM FARM LLC